Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease (F-IBDQ)

Study Description

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

The purpose of the study is to develop a validated French version of the IBDQ in a cohort of patients suffering from Inflammatory bowel diseases, namely Crohn's disease and Ulcerative Colitis.

Condition or disease	Intervention/treatment
Ulcerative Colitis; Crohn's Disease	Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)

Detailed Description:

Importance of measuring subjective aspects of the patient's health, often referred to as quality of life (QoL), become increasingly recognized and integrated into healthcare. For this purpose, The Inflammatory Bowel Disease Questionnaire (IBDQ) is a widely used questionnaire for QoL assessment specific for patients who suffer from inflammatory bowel diseases. However, the IBDQ was originally developed in a cohort of Canadian patients in English language. Since QoL is impacted by underlying cultural trends, any translation of the IBDQ should be reassessed in relation to its validity, reliability, and sensitivity to detect change in the new language and cultural context. While the linguistic French translation of the original IBDQ has been validated, the French IBDQ has never been tested adequately on a French cohort of patient that we aim to perform.

Study Design

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Actual Enrollment :	100 participants
Observational Model:	Cohort
Time Perspective:	Prospective
Official Title:	Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn's Disease
Actual Study Start Date :	December 2013
Actual Primary Completion Date :	April 2016
Actual Study Completion Date :	January 2017

Groups and Cohorts

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort	Intervention/treatment
Ulcerative Colitis and Crohn's Disease	Other: Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ)

Outcome Measures

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :

1. Internal validity, scale F-IBDQ [ Time Frame: Day1 and Month4 ]
   Chronbach's alpha coefficient, measured at the first visit and at the second visit.
2. External validity, questionnaire SF36 [ Time Frame: Day1 and Month4 ]
   Correlation with the French validated SF-36 and disease activity indexes (Harvey Bradshaw index for Crohn's disease and Simple Colitis Activity Index for ulcerative colitis, measured at the first visit and at the second visit.
3. Discriminant ability, disease activity indexes [ Time Frame: Day1 and Month4 ]
   Correlation with disease activity indexes, measured at the first visit and at the second visit.
4. Reliability, disease outcomes [ Time Frame: Day1 and Month4 ]
   Correlation with disease outcomes, measured at the first visit and at the second visit.

Eligibility Criteria

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patient with definite diagnosis of UC or CD for at least 6 months

Criteria

Inclusion Criteria:

• men and women ≥ 18 years of age,
• patient with definite diagnosis of UC or CD for at least 6 months

Exclusion Criteria:

• adults legally protected (under judicial protection, guardianship, or supervision), persons deprived of their liberty
• inability to comprehend or complete the self-administered questionnaire
• psychiatric diagnosis that prevents participation (many pts will have anxiety or depression and should not be excluded)
• stoma
• malignancy

Contacts and Locations

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

France
CHRU de Nancy
Nancy, France
Service des Maladies de l'Appareil Digestif, Hôpital de Pontchaillou, 2 rue Henri Le Guilloux
Rennes, France, 35033

Sponsors and Collaborators

Rennes University Hospital

Investigators

Principal Investigator:	Guillaume Bouguen	Rennes University Hospital

More Information

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party:	Rennes University Hospital
ClinicalTrials.gov Identifier:	NCT01891214 History of Changes
Other Study ID Numbers:	2013-A00144-41; LOC/12-17 Bouguen F-IBDQ ( Other Identifier: Rennes University Hospital )
First Posted:	July 3, 2013
Last Update Posted:	February 15, 2017
Last Verified:	February 2017

Keywords provided by Rennes University Hospital:

Inflammatory bowel diseases; Inflammatory Bowel Disease Questionnaire (IBDQ)

Additional relevant MeSH terms:

Crohn Disease; Colitis; Ulcer; Colitis, Ulcerative; Intestinal Diseases; Inflammatory Bowel Diseases	Gastroenteritis; Gastrointestinal Diseases; Digestive System Diseases; Colonic Diseases; Pathologic Processes